Compare IFS & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IFS | AMRX |
|---|---|---|
| Founded | 1897 | 2002 |
| Country | Peru | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.8B |
| IPO Year | 2014 | 2018 |
| Metric | IFS | AMRX |
|---|---|---|
| Price | $54.91 | $17.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $48.00 | $15.60 |
| AVG Volume (30 Days) | 267.1K | ★ 1.8M |
| Earning Date | 05-11-2026 | 05-01-2026 |
| Dividend Yield | ★ 3.85% | N/A |
| EPS Growth | N/A | ★ 157.89 |
| EPS | N/A | ★ 0.37 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | $7.38 | $7.13 |
| P/E Ratio | ★ $9.61 | $48.41 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $38.29 | $9.20 |
| 52 Week High | $61.38 | $19.26 |
| Indicator | IFS | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 40.54 | 49.62 |
| Support Level | $53.84 | $16.61 |
| Resistance Level | $60.91 | $18.13 |
| Average True Range (ATR) | 1.68 | 0.62 |
| MACD | -0.36 | -0.09 |
| Stochastic Oscillator | 21.52 | 45.76 |
Intercorp Financial Services Inc is a provider of banking, insurance, wealth management services, and payments for retail customers and commercial clients in Peru. Its purpose is centered around building financial well-being together. The company has three operating business segments: Banking, mainly loans, credit facilities, deposits, and current accounts; Insurance provides life annuity products with single-premium payment and conventional life insurance products, as well as other retail insurance products; and Wealth management provides brokerage and investment management services. Inteligo serves mainly Peruvian citizens.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.